You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes included elsewhere in this Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2020. Some of the information contained in this discussion and analysis, particularly with respect to our plans and strategy for our business and related financing, includes forward-looking statements within the meanings of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, including statements regarding expectations, beliefs, intentions or strategies for the future. When used in this report, the terms "anticipate," "believe," "estimate," "expect," "can," "continue," "could," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" and words or phrases of similar import, as they relate to our company or our management, are intended to identify forward-looking statements. We intend that all forward-looking statements be subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are only predictions and reflect our views as of the date they are made with respect to future events and financial performance, and we undertake no obligation to update or revise, nor do we have a policy of updating or revising, any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as may be required under applicable law. Forward-looking statements are subject to many risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements as a result of several factors including those set forth under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020, and in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021.

The Company notes that in addition to the description of historical facts contained herein, this report contains certain forward-looking statements that involve risks and uncertainties as detailed herein and from time to time in the Company's other filings with the Securities and Exchange Commission and elsewhere. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those, described in the forward-looking statements. These factors include, among others: (a) the Company's fluctuations in sales and operating results; (b) risks associated with international operations; (c) regulatory, competitive and contractual risks; (d) development risks; (e) the ability to achieve strategic initiatives, including but not limited to the ability to achieve sales growth across the business segments through a combination of enhanced sales force, new products, and customer service; and (f) pending litigation.





Overview and Outlook


The Company was incorporated on May 7, 2007 under the name, "Darkstar Ventures, Inc." under the laws of the State of Nevada. On November 12, 2019, the Company completed its merger with the Delaware corporation that was previously known as "Samsara Luggage, Inc." ("Samsara Delaware") in accordance with the terms of the Merger Agreement and Plan of Merger, dated as of May 10, 2019, (the "Merger Agreement") by and among the Company, Samsara Delaware, and Avraham Bengio, pursuant to which Samsara Delaware merged with and into the Company, with the Company being the surviving corporation (the "Merger"). Following the completion of the Merger, the business of the Company going forward became the business of Samsara Delaware prior to the Merger, namely, the development and sale of smart luggage products.





Recent Developments



Reverse Stock Split



On March 17, 2021, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada (the "Certificate of Change") to effect a reverse split of Company's common stock at a ratio of 1-for-7,000 (the "Reverse Stock Split"). The Reverse Stock Split took effect at the open of business on Tuesday, March 23, 2021. As a result of the Reverse Stock Split, each seven thousand (7,000) pre-split shares of common stock outstanding automatically combined into one (1) new share of common stock without any action on the part of the holders, and the number of outstanding shares common stock were reduced from 5,995,825,131 shares to 8,565,465 shares (subject to rounding of fractional shares).





                                       18




No fractional shares were issued in connection with the Reverse Stock Split. The Company issued one whole share of the post-Reverse Stock Split Common Stock to any stockholder who otherwise would have received a fractional share as a result of the Reverse Stock Split.

Increase in Authorized Share Capital

On October 5, 2020, the Board of Directors of the Company approved, and the holders of a majority of the outstanding shares of our common stock, par value $0.0001 per share, (the "Common Stock"), executed a written consent in lieu of a meeting that approved, amending the Company's Articles of Incorporation to increase the number of authorized shares of common stock from 5,000,000,000 to 7,500,000,000 (the "Authorized Capital Increase").

On November 3, 2020, the Company effected the Authorized Capital Increase by filing with the Secretary of State of the State of Nevada a Certificate of Amendment amending the Company's Articles of Incorporation to increase the number of authorized shares of common stock from 5,000,000,000 to 7,500,000,000.

YAII PN Ltd. Convertible Debentures

September 2020

On September 3, 2020, the Company entered into a Securities Purchase Agreement ("SPA") with YAII PN, Ltd. (the "Investor"), pursuant to which the Investor invested an aggregate amount of $220,000 in two tranches, and the Company issued convertible debentures and warrants to the Investor. The first tranche of the investment in the amount of $150,000 was provided upon signature of the SPA. The second tranche in the amount of $70,000 was provided on October 7, 2020. The funds are expected to be used to finance the Company's working capital and other general corporate needs. Each tranche of the investment will bear interest at an annual rate of ten percent (10%) and will be repayable after two years. Each tranche of the investment will be convertible at any time into shares of the Company's Common Stock at a conversion price equal to the lower of (a) $0.003 per share, or (b) 80% of the lowest the daily dollar volume-weighted average price for the Company's Common Stock during the 10 trading days immediately preceding the conversion date.

As part of the transaction, the Company issued to the Investor warrants to purchase an aggregate of 18,333,333 shares of Common Stock, at an exercise price equal to $0.003. The term of each warrant is five years from the issue date. Each warrant may be exercised by cash payment or through cashless exercise by the surrender of warrant shares having a value equal to the exercise price of the portion of the warrant being exercised.

The Company undertook to increase its authorized shares of Common Stock to at least 7,000,000,000 within 90 days of the closing.

The foregoing descriptions of the terms and conditions of the SPA and the convertible debentures are qualified in their entirety by reference to the full text of the SPA and the convertible debentures.

The Company issued the convertible debentures and the warrants under the exemptions from registration provided by Section 4(a)(2) of the Securities Act of 1933. The Company expect that any issuance of shares of common stock pursuant to the terms of the convertible debentures and the warrants will be exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and regulations promulgated thereunder. None of these transactions involved any underwriters, underwriting discounts or commissions, or any public offering, and the Investor had adequate access, through their relationships with the Company, to information about the Company.

The shares of common stock to be issued in the event of conversion of the convertible debentures and upon exercise of the warrants will not be registered under the Securities Act, or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.





                                       19





April 2021

On April 6, 2021, the Company entered into a Securities Purchase Agreement ("Second SPA") with the Investor, pursuant to which the Investor invested $150,000, and the Company issued a convertible debenture and warrants to the Investor. The $150,000 investment was provided upon signature of the Second SPA. The investment will bear interest at an annual rate of ten percent (10%) and will be repayable after two years. The investment will be convertible at any time into shares of the Company's Common Stock at a conversion price equal to the lower of (a) $3.46, or (b) 80% of the lowest the daily dollar volume-weighted average price for the Company's Common Stock during the 10 trading days immediately preceding the conversion date.

As part of the transaction, the Company issued to the Investor warrants to purchase an aggregate of 10,838 shares of Common Stock, at an exercise price equal to $3.46. The term of each warrant is five years from the issue date. Each warrant may be exercised by cash payment or through cashless exercise by the surrender of warrant shares having a value equal to the exercise price of the portion of the warrant being exercised.

September 2021

During the third quarter of 2021, the Company increased its R&D, manufacturing capabilities and strategic marketing activities in preparation for the launch of the first product from its Next Gen line of travel luggage and coordinating accessories. Despite the interruptions with the global supply chain, the Company expects to establish a reliable production line that will be able to meet the anticipated increase in demand of travel products in 2022.





Results of Operations


Nine months ended September 30, 2021 compared to the nine months ended September 30, 2020





Revenue


The Company generates revenues through the sale and distribution of smart luggage products and sales through the Sarah & Sam fashion brand. Revenues during the nine months ended September 30, 2021 totaled $294,000 compared to $402,000 for the nine months ended June 30, 2020. The decrease in the total revenue is mainly due to the Essentials Kits sales in second quarter of 2020, that increased sales dramatically, offering COVID essentials products that were in high demand at the beginning of the pandemic. Revenues for the quarter ending September 30, 2021 grew by 200% with an increase in new cluster sales from its newest vertical Sarah and Sam. Samsara launched Sarah & Sam, a fashion and lifestyle collection in the fourth quarter of the 2020 fiscal year. Sarah & Sam is a part of Samsara Direct, a new business model initiated in response to the travel restrictions enforced due to the coronavirus pandemic. Samsara Direct leverages the company's established digital assets and manufacturing and fulfillment supply chain capabilities to offer additional consumer products that respond to the changing needs of the market.





Costs of Revenue


Costs of revenue consists of the purchase of raw materials and the cost of production. Cost of revenues during the nine months ended September 30, 2021 totaled $236,000 compared to $234,000 for the nine months ended September 30, 2020. The decrease in the costs of revenue is mainly due to decrease in sales as described above.





Gross Profit


During the nine months ended September 30, 2021, Gross Profit totaled $58,000 representing a Gross Profit margin of 20%. During the nine months ended September 30, 2020, Gross Profit totaled $168,000, representing a Gross Profit margin of 42%.





Operating Expenses



Operating expenses totaled $1,262,000 during the nine months ended September 30, 2021, compared to $1,179,000 during the nine months ended September 30, 2020, representing a net increase of $83,000.





                                       20





Financing Income (expenses)


Financing expenses totaled $1,820,000 during the nine months ended September 30, 2021 compared to a financing income of $192,000 during the nine months ended September 30, 2020 representing a net increase of 1,628,000. The increase in the financing expenses is mainly due to increase in the expenses in respect of warrants issued and convertible component in convertible loan, net interest expenses mostly attributed to the conversion of the warrants into the Common Shares of the Company.





Net Profit/Loss


We realized a net loss of $3,024,000 for the nine months ended September 31, 2021, as compared to a net loss of $880,000 for the nine months ended September 31, 2020, for the reasons described above.

Three months ended September 30, 2021 compared to the three months ended September 30, 2020





Revenue


The Company generates revenues through the sale and distribution of smart luggage products and sales through the Sarah & Sam fashion brand. Revenues during the three months ended September 30, 2021 totaled $110,000 compared to $51,000 for the three months ended September 30, 2020. The increase in the total revenue is mainly due to Sarah & Sam fashion brand. Revenues generated exclusively by Sarah & Sam during the three months ended September 30, 2021 totaled $,000 with a gross profit of $,000 which represents a gross profit margin of %.





Costs of Revenue



Costs of revenue consists of the purchase of raw materials and the cost of production. Cost of revenues during the three months ended September 30, 2021 totaled $95,000 compared to $48,000 for the three months ended September 30, 2020. The increase in the costs of revenue is mainly due to increase in sales as described above.





Gross Profit


During the three months ended September 30, 2021, Gross Profit totaled $15,000, representing a Gross Profit margin of 13.6%. During the three months ended September 30, 2020, Gross Profit totaled $3,000, representing a Gross Profit margin of 6%.





Operating Expenses



Operating expenses totaled $,000 during the three months ended September 30, 2021, compared to $389,000 during the three months ended September 30, 2020, representing a net decrease of $,000. The decrease in the operating expenses is mainly due to decrease in the research and development, selling and marketing expenses.





Financing Income (expenses)



Financing expenses totaled $77,000 during the three months ended September 30, 2021 compared to a financing expenses of $269,000 during the three months ended September 30, 2020 representing a net decrease of 192,000.





Net Profit/Loss


We realized a net loss of $547,000 for the three months ended September 31, 2021, as compared to a net loss of $655,000 for the three months ended September 31, 2020, for the reasons described above.

Liquidity and Capital Resources

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.





                                       21




As of September 30, 2021, the Company had $670,000 of cash, total current assets of $752,000, and total current liabilities of $1,605,000, creating a working capital deficit of $853,000. As of December 31, 2020, the Company had $54,000 of cash, total current assets of $211,000 and total current liabilities of $1,127,000 creating a working capital deficit of $916,000. The decrease in our working capital deficit was mainly attributable to decrease of $616,000 in cash and cash equivalents.

Net cash used in operating activities was $562,000 for the nine months ended September 30, 2021, as compared to cash used in operating activities of $533,000 for the nine months ended September 30, 2020. The Company's primary uses of cash have been for research and development expenses, sales and marketing expenses, and working capital purposes.

Net cash provided by financing activities was $1,178,000 for the nine months ended September 30, 2021, as compared to $191,000 for the nine months ended September 30, 2020.

We have principally financed our operations through the sale of our common stock and the issuance of debt. Due to our operational losses, we relied to a large extent on financing our cash flow requirements through issuance of common stock and debt. There can be no assurance we will be successful in raising the necessary funds to execute our business plan.

Necessity of Additional Financing

Securing additional financing is critical to implementation of our business plan. If and when we obtain the required additional financing, we should be able to fully implement our business plan. In the event we are unable to raise any additional funds we will not be able to pursue our business plan, and we may fail entirely. We currently have no committed sources of financing.





Going Concern Consideration


The above conditions raise substantial doubt about our ability to continue as a going concern. Our independent auditors included an explanatory paragraph in their report on the accompanying financial statements regarding concerns about our ability to continue as a going concern. Our financial statements contain additional note disclosures describing the circumstances that lead to this disclosure by our independent auditors. Although we anticipate that our current operations will provide us with cash resources, we believe existing cash will not be sufficient to fund planned operations and projects through the next 12 months. Therefore, we believe we will need to increase our sales, attain profitability, and raise additional funds to finance our future operations. Any meaningful equity or debt financing will likely result in significant dilution to our existing stockholders. There is no assurance that additional funds will be available on terms acceptable to us, or at all.

To address these risks, we must, among other things, implement and successfully execute our business and marketing strategy surrounding our products, continually develop and upgrade our website, respond to competitive developments, lower our financing costs, and attract, retain and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial condition and results of operations.





Seasonality


We do not expect our sales to be impacted by seasonal demands for our products.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.


                                       22

© Edgar Online, source Glimpses